Peptide Sequence (IUPAC Condensed): H-Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val-OH
Compounded Tirzepatide can be prescribed off-label for weight loss, including for people with diabetes
and Zepbound (KwikPen) at $299/month for the first month, rising to $399$449/month ongoing
The C-terminal region typically encodes the activity of the effector and is required for compatible/incompatible interactions to occur (Bos et al., 2006
The use of GLP-1 RAs is increasingly common, not only for T2DM but also for obesity in both youth and adults, though it is associated with numerous registered serious adverse effects
Starting July 1, 2026, Medicare will cover FDA-approved weight-loss medications like Wegovy (semaglutide) and Zepbound (tirzepatide) for a flat $50 per month through a new initiative called the Medicare GLP-1 Bridge Program